logo
Select company
Select metric
$ 41.39MWorking Capital
VS
Market
45
Sector
43
Industry
43
History
85
$ 2.37Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 65.48M$ 24.09M$ 41.39M
3/31/2025$ 60.51M$ 24.32M$ 36.19M
12/31/2024$ 60.08M$ 25.62M$ 34.46M
9/30/2024$ 47.85M$ 24.22M$ 23.63M
6/30/2024$ 77.37M$ 57.97M$ 19.39M
3/31/2024$ 75.4M$ 54.83M$ 20.58M
12/31/2023$ 69.93M$ 45.53M$ 24.4M
9/30/2023$ 72.62M$ 43.36M$ 29.26M
6/30/2023$ 73.58M$ 23.11M$ 50.47M
3/31/2023$ 55.4M$ 31.52M$ 23.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 16.44M.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average Working Capital has been $ 20.98M.
  • The median Working Capital for PROTALIX BIOTHERAPEUTICS INC during this period was $ 22.42M
  • PROTALIX BIOTHERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 50.47M.
  • The lowest Working Capital recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe $ -30.75M

PROTALIX BIOTHERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
CSBR : CHAMPIONS ONCOLOGY INC $ -1.68MTHTX : THERATECHNOLOGIES INC $ -4.49MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 129.92MSPRO : SPERO THERAPEUTICS INC $ 44.46MENTA : ENANTA PHARMACEUTICALS INC $ 178.16MCELU : CELULARITY INC $ -51.96MIVVD : INVIVYD INC $ 14.83MDOMH : DOMINARI HOLDINGS INC $ 43.82MSGMO : SANGAMO THERAPEUTICS INC $ 2.23MALEC : ALECTOR INC $ 234.82M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 60.33M ] - LiabilitesC [ $ 43.9M ]
(=) Working Capital [ $ 16.44M ]

PLX - Working Capital, Last 5 years

$ -30.75M

Minimum

Dec 31, 2020

$ 50.47M

Maximum

Jun 30, 2023

$ 20.98M

Average

$ 22.42M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -465.2M
max$ 607.04M
average$ 96.5M
median$ 32.21M
std$ 173.86M